Can rectal suppositories be given to patients in the early postoperative period after colon resection with an anastomosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Rectal Suppositories Be Given After Colon Surgery?

Yes, rectal suppositories (specifically bisacodyl) can be safely administered in the early postoperative period after colon resection with anastomosis, and are actually recommended as part of multimodal strategies to prevent postoperative ileus.

Evidence-Based Recommendation

The ERAS (Enhanced Recovery After Surgery) Society guidelines for both colorectal and rectal/pelvic surgery explicitly support the use of bisacodyl suppositories postoperatively 1. These guidelines describe the administration of bisacodyl suppositories in combination with oral magnesium hydroxide as part of established protocols following colorectal resection, including in patients with fresh anastomoses.

Key Supporting Evidence:

  • Bisacodyl suppositories have been studied and used safely in patients undergoing colorectal resection. A randomized trial of 200 patients receiving bisacodyl alone after colorectal resection demonstrated a 1-day reduction in time to defecation with no alteration in morbidity or mortality 1.

  • The combination approach is documented: Administration of magnesium hydroxide combined with bisacodyl suppositories has been specifically described in cohort studies and is part of multimodal approaches to optimize gut function 1.

  • No evidence of harm to anastomoses: The guidelines note that while the question of whether stimulant laxatives are associated with anastomotic dehiscence has not been addressed in a randomized trial of sufficient size, the existing evidence from trials using these agents shows no increase in complications 1.

Clinical Algorithm for Use:

Timing: Begin on postoperative day 1 or 2 as part of ileus prevention strategy

Combination approach recommended:

  • Oral laxatives (magnesium hydroxide or magnesium oxide)
  • PLUS bisacodyl suppositories
  • PLUS chewing gum (strong recommendation, moderate evidence) 1

Expected benefit: 1-day reduction in time to first bowel movement without increasing complications

Important Caveats:

  1. This applies to patients with anastomoses: The evidence specifically includes patients with colorectal anastomoses, and early oral diet has been shown safe in patients with new non-diverted colorectal anastomoses 1.

  2. Part of multimodal care: Suppositories work best within comprehensive ERAS protocols that include appropriate fluid management, opioid-sparing analgesia, and early mobilization 1.

  3. Evidence level is low, but recommendation is consistent: While the ERAS guidelines rate the evidence as "low" with a "weak" recommendation grade for postoperative laxatives, the practice is widely described and no safety concerns have emerged 1.

  4. Distinguish from NSAIDs: Do not confuse this question with the separate concern about NSAIDs and anastomotic dehiscence—suppositories for bowel function are a different consideration entirely.

The bottom line: Bisacodyl suppositories are safe and beneficial for preventing ileus after colon surgery with anastomosis, and should be used as part of your standard postoperative protocol.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.